Hereditary Transthyretin Amyloidosis: How to Differentiate Carriers and Patients Using Speckle-Tracking Echocardiography.

Daniela Di Lisi Filippo BrighinaGirolamo MannoFrancesco ComparatoVincenzo Di StefanoFrancesca MacaioneGiuseppe DamerinoLeandro Di CaccamoNoemi CannizzoAntonella OrtelloAlfredo R GalassiGiuseppina Novo

Published in: Diagnostics (Basel, Switzerland) (2023)

Our study suggests the diagnostic role of the SAB and RAS in cardiac amyloidosis. The SAB and RAS showed a gradual increase from carriers to patients with neurological and cardiac diseases. Thus, these parameters, in addition to atrial stiffness, could be used to monitor carriers. More extensive data are needed.

Keyphrases

left ventricular
end stage renal disease
wild type
newly diagnosed
chronic kidney disease
ejection fraction
computed tomography
prognostic factors
multiple myeloma
atrial fibrillation
pulmonary hypertension
electronic health record
left atrial
big data
machine learning
mitral valve